drugset / Trial / NCT00179244

Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression

NCT00179244

RandomizedCrossoverOpen-label

Summary

The purpose of this study is to evaluate the comparative effectiveness of Risperdal (risperidone) or bupropion ER (extended release) combined with a SSRI medication and to test the relative safety of the combinations.

Timeline

Start
2004-07
Primary completion
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule
Subject Risperidone Other / unclassified